Biphasic time course of the changes in aldosterone biosynthesis under high-salt conditions in dahl salt-sensitive rats

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 32, Issue 5, 2012, Pages 1194-1203

  Morizane, Shintaro ^a,b   Mitani, Fumiko ^a,e   Ozawa, Kae ^a,b   Ito, Kentaro ^a,e   Matsuhashi, Tomohiro ^a   Katsumata, Yoshinori ^a   Ito, Hideyuki ^a   Yan, Xiaoxiang ^a   Shinmura, Ken ^b   Nishiyama, Akira ^c   Honma, Seijiro ^d   Suzuki, Takeshi ^b   Funder, John W ^f   Fukuda, Keiichi ^a   Sano, Motoaki ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KEIO UNIVERSITY   (Japan)

^c KAGAWA UNIVERSITY   (Japan)

^d Grelan Pharmaceutical Co Ltd   (Japan)

^e WASEDA UNIVERSITY   (Japan)

^f HUDSON INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

12 15 lipoxygenase; Aldosterone; Angiotensin II; CYP11B2; Electrospray ionization; Gene expression; Liquid chromatography; Tandem mass spectrometry

Indexed keywords

ALDOSTERONE; ALDOSTERONE SYNTHASE; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN II; SODIUM CHLORIDE;

ADRENAL GLAND; ADRENALECTOMY; ANIMAL EXPERIMENT; ARTICLE; BIOSYNTHESIS; CONTROLLED STUDY; DAHL SALT SENSITIVE RAT; DIETARY INTAKE; HEART; HEART LEFT VENTRICLE FAILURE; KIDNEY FAILURE; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; UPREGULATION; ZONA GLOMERULOSA;

ADRENAL GLANDS; ALDOSTERONE; ANIMALS; DISEASE MODELS, ANIMAL; HYPERTENSION; IMMUNOHISTOCHEMISTRY; MALE; MYOCARDIUM; RATS; RATS, INBRED DAHL; RENIN-ANGIOTENSIN SYSTEM; SODIUM, DIETARY; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION;

EID: 84862816267     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATVBAHA.111.242719     Document Type: Article

References (33)

1. Fujita T, Henry WL, Bartter FC, Lake CR, Delea CS. Factors influencing blood pressure in salt-sensitive patients with hypertension. Am J Med. 1980;69:334-344. (Pubitemid 10059678)
2. Morimoto A, Uzu T, Fujii T, Nishimura M, Kuroda S, Nakamura S, Inenaga T, Kimura G. Sodium sensitivity and cardiovascular events in patients with essential hypertension. Lancet. 1997;350:1734-1737. (Pubitemid 28036672)
3. Fujita T. Aldosterone in salt-sensitive hypertension and metabolic syndrome. J Mol Med (Berl). 2008;86:729-734.
4. Bader M, Ganten D. Update on tissue renin-angiotensin systems. J Mol Med. 2008;86:615-621.
5. Ryan JW. Renin-like enzyme in the adrenal gland. Science. 1967;158:1589-1590.
6. Ganten D, Ganten U, Kubo S, Granger P, Nowaczynski W, Boucher R, Genest J. Influence of sodium, potassium, and pituitary hormones on iso-renin in rat adrenal glands. Am J Physiol. 1974;227:224-229.
7. Naruse M, Inagami T. Markedly elevated specific renin levels in the adrenal in genetically hypertensive rats. Proc Natl Acad Sci USA. 1982;79:3295-3299. (Pubitemid 12008393)
8. Mullins JJ, Peters J, Ganten D. Fulminant hypertension in transgenic rats harbouring the mouse ren-2 gene. Nature. 1990;344:541-544.
9. Sander M, Bader M, Djavidani B, Maser-Gluth C, Vecsei P, Mullins J, Ganten D, Peters J. The role of the adrenal gland in hypertensive transgenic rat tgr(mren2)27. Endocrinology. 1992;131:807-814.
10. Peters J, Munter K, Bader M, Hackenthal E, Mullins JJ, Ganten D. Increased adrenal renin in transgenic hypertensive rats, tgr(mren2)27, and its regulation by cAMP, angiotensin II, and calcium. J Clin Invest. 1993;91:742-747. (Pubitemid 23095245)
11. Dahl LK, Heine M, Tassinari L. Effects of chronic excess salt ingestion: evidence that genetic factors play an important role in susceptibility to experimental hypertension. J Exp Med. 1962;115:1173-1190.
12. Rapp JP, Tan SY, Margolius HS. Plasma mineralocorticoids, plasma renin, and urinary kallikrein in salt-sensitive and salt-resistant rats. Endocr Res Commun. 1978;5:35-41. (Pubitemid 9028132)
13. Baba K, Mulrow PJ, Franco-Saenz R, Rapp JP. Suppression of adrenal renin in Dahl salt-sensitive rats. Hypertension. 1986;8:1149-1153. (Pubitemid 17228786)
14. Cover CM, Wang JM, St Lezin E, Kurtz TW, Mellon SH. Molecular variants in the p450c11as gene as determinants of aldosterone synthase activity in the Dahl rat model of hypertension. J Biol Chem. 1995;270:16555-16560.
15. Matsukawa N, Nonaka Y, Higaki J, Nagano M, Mikami H, Ogihara T, Okamoto M. Dahl's salt-resistant normotensive rat has mutations in cytochrome p450(11 beta), but the salt-sensitive hypertensive rat does not. J Biol Chem. 1993;268:9117-9121. (Pubitemid 23118710)
16. Cicila GT, Garrett MR, Lee SJ, Liu J, Dene H, Rapp JP. High-resolution mapping of the blood pressure QTL on chromosome 7 using Dahl rat congenic strains. Genomics. 2001;72:51-60. (Pubitemid 32225179)
17. Pacha J, Pohlova I. The influence of high salt intake on intestinal Na,K-ATPase in Wistar and Dahl rats. Acta Physiol Scand. 1993;148:69-75. (Pubitemid 23153343)
18. Whitescarver SA, Ott CE, Jackson BA, Guthrie GP Jr, Kotchen TA. Salt-sensitive hypertension: contribution of chloride. Science. 1984;223:1430-1432. (Pubitemid 14161011)
19. Nishikimi T, Yoshihara F, Horinaka S, Kobayashi N, Mori Y, Tadokoro K, Akimoto K, Minamino N, Kangawa K, Matsuoka H. Chronic administration of adrenomedullin attenuates transition from left ventricular hypertrophy to heart failure in rats. Hypertension. 2003;42:1034-1041. (Pubitemid 37413749)
20. Ohtani T, Ohta M, Yamamoto K, Mano T, Sakata Y, Nishio M, Takeda Y, Yoshida J, Miwa T, Okamoto M, Masuyama T, Nonaka Y, Hori M. Elevated cardiac tissue level of aldosterone and mineralocorticoid receptor in diastolic heart failure: beneficial effects of mineralocorticoid receptor blocker. Am J Physiol Regul Integr Comp Physiol. 2007;292:R946-R954. (Pubitemid 46207752)
21. Yamashita K, Okuyama M, Nakagawa R, Honma S, Satoh F, Morimoto R, Ito S, Takahashi M, Numazawa M. Development of sensitive derivatization method for aldosterone in liquid chromatography-electrospray ionization tandem mass spectrometry of corticosteroids. J Chromatogr A. 2008;1200:114-121.
22. Ogishima T, Suzuki H, Hata J, Mitani F, Ishimura Y. Zone-specific expression of aldosterone synthase cytochrome p-450 and cytochrome p-45011 beta in rat adrenal cortex: histochemical basis for the functional zonation. Endocrinology. 1992;130:2971-2977.
23. Mitani F, Suzuki H, Hata J, Ogishima T, Shimada H, Ishimura Y. A novel cell layer without corticosteroid-synthesizing enzymes in rat adrenal cortex: histochemical detection and possible physiological role. Endocrinology. 1994;135:431-438. (Pubitemid 24203848)
24. Nishiyama A, Seth DM, Navar LG. Renal interstitial fluid concentrations of angiotensins I and II in anesthetized rats. Hypertension. 2002;39:129-134. (Pubitemid 34098101)
25. Sakoda M, Ichihara A, Kurauchi-Mito A, Narita T, Kinouchi K, Murohashi-Bokuda K, Saleem MA, Nishiyama A, Suzuki F, Itoh H. Aliskiren inhibits intracellular angiotensin II levels without affecting (pro)renin receptor signals in human podocytes. Am J Hypertens. 2010;23:575-580.
26. Inagaki K, Koyanagi T, Berry NC, Sun L, Mochly-Rosen D. Pharmacological inhibition of epsilon-protein kinase C attenuates cardiac fibrosis and dysfunction in hypertension-induced heart failure. Hypertension. 2008;51:1565-1569.
27. Kawajiri H, Zhuang D, Qiao N, Yoshimoto T, Yamamoto M, Iseki S, Hamaguchi K. Expression of arachidonate 12-lipoxygenase in rat tissues: a possible role in glucagon secretion. J Histochem Cytochem. 2000;48:1411-1419.
28. Nadler JL, Natarajan R, Stern N. Specific action of the lipoxygenase pathway in mediating angiotensin II-induced aldosterone synthesis in isolated adrenal glomerulosa cells. J Clin Invest. 1987;80:1763-1769. (Pubitemid 18007153)
29. Natarajan R, Stern N, Hsueh W, Do Y, Nadler J. Role of the lipoxygenase pathway in angiotensin II-mediated aldosterone biosynthesis in human adrenal glomerulosa cells. J Clin Endocrinol Metab. 1988;67:584-591.
30. Gomez-Sanchez EP, Ahmad N, Romero DG, Gomez-Sanchez CE. Origin of aldosterone in the rat heart. Endocrinology. 2004;145:4796-4802. (Pubitemid 39551092)
31. Mizuno Y, Yoshimura M, Yasue H, Sakamoto T, Ogawa H, Kugiyama K, Harada E, Nakayama M, Nakamura S, Ito T, Shimasaki Y, Saito Y, Nakao K. Aldosterone production is activated in failing ventricle in humans. Circulation. 2001;103:72-77. (Pubitemid 32050438)
32. Tsutamoto T, Wada A, Maeda K, Mabuchi N, Hayashi M, Tsutsui T, Ohnishi M, Sawaki M, Fujii M, Matsumoto T, Horie H, Sugimoto Y, Kinoshita M. Spironolactone inhibits the transcardiac extraction of aldosterone in patients with congestive heart failure. J Am Coll Cardiol. 2000;36:838-844.
33. Nagase M. Activation of the aldosterone/mineralocorticoid receptor system in chronic kidney disease and metabolic syndrome. Clin Exp Nephrol. 2010;14:303-314.